Acorai manufactures a non-invasive intracardiac pressure monitoring device that utilizes a unique combination of seismic, acoustic, visual, and electric sensors to provide accurate and actionable insights for heart failure management. This technology enables healthcare professionals to make informed decisions based on continuous monitoring, ultimately improving patient outcomes and reducing readmission rates.
Funding
$13.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Heart failure management relies on invasive methods to measure intracardiac pressures, limiting the ability for frequent and convenient monitoring. This can lead to delayed detection of worsening conditions, increased readmission rates, and complications due to suboptimal medication adjustments.
Solution
Acorai is developing a non-invasive intracardiac pressure monitoring device designed to provide accurate and actionable insights for personalized heart failure treatment. The Acorai Heart Monitor utilizes the SAVE Sensor System, a novel combination of seismic, acoustic, visual, and electric sensors, along with state-of-the-art machine learning, to estimate pulmonary pressure. The device's handheld and portable form factor aims to integrate easily into daily clinical practice, offering continuous monitoring to support informed decision-making across all stages of heart failure. The goal is to enable data-driven insights that can alleviate healthcare burdens by reducing readmission rates, optimizing length of stay, and preventing complications.
Target Audience
The primary target audience includes healthcare professionals involved in heart failure management, such as cardiologists, nurses, and other clinicians in hospitals and outpatient settings.
Features
- SAVE Sensor System: Combines seismic, acoustic, visual, and electric sensors for measuring intracardiac pressures non-invasively.
- State-of-the-art machine learning: Built on proprietary datasets and data partnerships with leading hospitals for accurate pressure estimations.
- Handheld and portable form factor: Designed for easy integration into daily clinical workflows.
- Accurate, absolute, and actionable insights: Provides continuous information to support clinical decision-making.
- Ongoing clinical validation: The CAPTURE-HF study aims to confirm the monitor's ability to deliver actionable information comparable to invasive methods.